Annual Accounts Payable
$3.52 M
+$193.00 K+5.81%
December 31, 2023
Summary
- As of March 2, 2025, FDMT annual accounts payable is $3.52 million, with the most recent change of +$193.00 thousand (+5.81%) on December 31, 2023.
- During the last 3 years, FDMT annual accounts payable has risen by +$1.73 million (+96.70%).
- FDMT annual accounts payable is now -26.22% below its all-time high of $4.76 million, reached on December 31, 2021.
Performance
FDMT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.92 M
-$507.00 K-14.78%
September 30, 2024
Summary
- As of March 2, 2025, FDMT quarterly accounts payable is $2.92 million, with the most recent change of -$507.00 thousand (-14.78%) on September 30, 2024.
- Over the past year, FDMT quarterly accounts payable has dropped by -$1.79 million (-37.96%).
- FDMT quarterly accounts payable is now -38.62% below its all-time high of $4.76 million, reached on December 31, 2021.
Performance
FDMT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
FDMT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.8% | -38.0% |
| 3 y3 years | +96.7% | -38.0% |
| 5 y5 years | +268.4% | -38.0% |
FDMT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.2% | +5.8% | -38.6% | +97.6% |
| 5 y | 5-year | -26.2% | +101.5% | -38.6% | +127.7% |
| alltime | all time | -26.2% | +664.1% | -38.6% | +206.5% |
4D Molecular Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.92 M(-14.8%) |
| Jun 2024 | - | $3.43 M(-18.6%) |
| Mar 2024 | - | $4.22 M(+20.0%) |
| Dec 2023 | $3.52 M(+5.8%) | $3.52 M(-25.4%) |
| Sep 2023 | - | $4.71 M(+34.9%) |
| Jun 2023 | - | $3.49 M(+45.1%) |
| Mar 2023 | - | $2.41 M(-27.5%) |
| Dec 2022 | $3.32 M | $3.32 M(+124.5%) |
| Sep 2022 | - | $1.48 M(-55.4%) |
| Jun 2022 | - | $3.32 M(+23.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.68 M(-43.7%) |
| Dec 2021 | $4.76 M(+166.6%) | $4.76 M(+28.3%) |
| Sep 2021 | - | $3.71 M(+89.2%) |
| Jun 2021 | - | $1.96 M(+52.8%) |
| Mar 2021 | - | $1.28 M(-28.1%) |
| Dec 2020 | $1.79 M(+2.5%) | $1.79 M(+38.3%) |
| Sep 2020 | - | $1.29 M(-25.9%) |
| Dec 2019 | $1.74 M(+82.8%) | $1.74 M(+56.4%) |
| Jun 2019 | - | $1.11 M(+16.9%) |
| Dec 2018 | $954.00 K(+107.4%) | $954.00 K |
| Dec 2017 | $460.00 K | - |
FAQ
- What is 4D Molecular Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual accounts payable year-on-year change?
- What is 4D Molecular Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly accounts payable year-on-year change?
What is 4D Molecular Therapeutics annual accounts payable?
The current annual accounts payable of FDMT is $3.52 M
What is the all time high annual accounts payable for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual accounts payable is $4.76 M
What is 4D Molecular Therapeutics annual accounts payable year-on-year change?
Over the past year, FDMT annual accounts payable has changed by +$193.00 K (+5.81%)
What is 4D Molecular Therapeutics quarterly accounts payable?
The current quarterly accounts payable of FDMT is $2.92 M
What is the all time high quarterly accounts payable for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly accounts payable is $4.76 M
What is 4D Molecular Therapeutics quarterly accounts payable year-on-year change?
Over the past year, FDMT quarterly accounts payable has changed by -$1.79 M (-37.96%)